Search academic texts

Information × Registration Number 0211U008709, 0107U001555 , R & D reports Title Development of methods of prophylactic and treatment of diseases which take place from a metabolic syndrome, by preparations, wich stimulants the peroxisome proliferator-activated receptors (PPAR-gamma), by the improvement of criteria of diagnostics popup.stage_title Head Kaidashev Igor Petrovich, Registration Date 07-09-2011 Organization Ukrainian Ministry of the Health Public Service, Ukrainian Medical Stomatological Academia, popup.description2 Shown that the using of piohlitazone or a combination of metformin and ramipril in patients with metabolic syndrome and type 2 diabetes leads to lower insulin resistance, normalization of glucose and lipid metabolism, reduces systemic inflammation, improve the clinical course of disease and increases the effectiveness of standard therapy. Increasing the level of ceruloplasmin in dyslipidemia may be considered as a risk markers of inflammation, the increasing of the number of circulating CD32+CD40+ endothelial parts with increased concentration of big endothelin is a marker of endothelial damage. To assess insulin resistance we used the proposed index and a formula for its calculation. The first time the distribution of lipoprotein lipase polymorphism in healthy men and men with the presence of cardiovascular disease in Cherkasy population. Product Description popup.authors Весніна Л.Е. Куценко Л.О. Куценко Н.Л. Расін М.С. Савченко Л.Г. Шликова О.А. popup.nrat_date 2020-04-02 Close